Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. The therapies will target truncal (also known as clonal) tumour neo-antigens, unique flags to the immune system present on the surface of every cancer cell. These truncal neo-antigens are created early in the cancer’s evolution and present on all cancer cells in an individual patient’s tumour but not on healthy cells, so could allow scientists to target and destroy tumours without harming healthy tissues.
Achilles Therapeutics brings together four scientific Founders with world leading expertise in the understanding of cancer evolution, bioinformatics and the development of immunotherapies.
Company Details
- Employees
- 59
- Founded
- -
- Address
- 245 Hammersmith Road, Hammersmith,england W6 8pw,united Kingdom
- Phone
- +44 (0)1438 906 906
- in****@****stx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- achillestx.com
- HQ
- Hammersmith, England
Achilles Therapeutics Plc Questions
Achilles Therapeutics Plc's helpline number is +44 (0)1438 906 906
Achilles Therapeutics Plc's website is achillestx.com
Achilles Therapeutics Plc's LinkedIn profile is https://uk.linkedin.com/company/achillestx.com
Achilles Therapeutics Plc has
59 employees.
View email and phone details for 59
employees at Achilles Therapeutics Plc.
Achilles Therapeutics Plc's industry is
Biotechnology Research
Achilles Therapeutics Plc's top competitors are
Immunocore,
Quell Therapeutics,
Evox Therapeutics Ltd,
Adaptimmune,
Vertex Pharmaceuticals,
Aviadobio,
Autolus Therapeutics,
Cell And Gene Therapy Catapult,
Meiragtx,
Orchard Therapeutics - U.s..
Achilles Therapeutics Plc's support email address is info@achillestx.com
Achilles Therapeutics Plc's categories are Biotechnology Research
Achilles Therapeutics Plc's founding year is 2016
